Sunday 11 October 2026 Export all EQ data to Excel Powerpack

Equillium, Inc.

EQ Healthcare Biotechnology

Equillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023. In the quarter to June 2026, revenue fell 52.3%, EPS grew 75.0% and free cash flow fell 38.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.

1.41 0.03 −2.08%
Market cap
$91.3M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
3/9
Altman Z
−6.75
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Total current assets
31.04 24.98 49.35 76.74 83.37 85.17 55.43 67.10 7.15
Total non-current assets
0.85 0.63 1.18 1.69 2.04 0.25 0.11 0.06 0.00
Total Assets
31.89 25.60 50.53 78.42 85.41 85.43 55.54 67.16 7.15
Total current liabilities
2.93 6.36 27.57 32.04 8.92 7.25 3.88 2.03 0.57
Total non-current liabilities
0.36 0.19 0.38 14.44 9.99 8.33 9.81 0.20 8.83
Total liabilities
3.29 6.54 27.96 46.48 18.90 15.57 13.69 2.23 9.40
Common Equity (Total)
28.60 19.06 22.57 31.94 66.51 69.85 41.85 64.94 (2.25)
Shareholders Equity (Total)
28.60 19.06 22.57 31.94 66.51 69.85 41.85 64.94 (2.25)
Total Debt
— — — 8.95 10.18 9.94 9.68 — 8.06

Show all line items

In millions of $ except per-share values · columns are period end dates